US Stock MarketDetailed Quotes
ANTH Anthera Pharmaceuticals Inc
- 0.000200
- 0.0000000.00%
15min DelayClose Nov 25 16:00 ET
5.24KMarket Cap0.00P/E (TTM)
0.000000High0.000000Low1.60KVolume0.000000Open0.000200Pre Close0.00Turnover0.01%Turnover Ratio0.00P/E (Static)26.18MShares0.00020052wk High0.00P/B4.79KFloat Cap0.00000152wk Low--Dividend TTM23.96MShs Float581.120000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
Anthera Pharmaceuticals Inc Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2018 | (FY)Dec 31, 2017 | (Q4)Dec 31, 2017 | (Q3)Sep 30, 2017 | (Q2)Jun 30, 2017 | (Q1)Mar 31, 2017 | (FY)Dec 31, 2016 | (Q4)Dec 31, 2016 | (Q3)Sep 30, 2016 | (Q2)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -60.85%8.09M | -89.46%2.2M | -89.46%2.2M | -81.34%6.08M | -60.87%11.15M | -45.48%20.65M | -55.61%20.84M | -55.61%20.84M | -41.59%32.57M | -19.62%28.5M |
| -Cash and cash equivalents | -60.85%8.09M | -89.46%2.2M | -89.46%2.2M | -81.34%6.08M | -60.87%11.15M | -45.48%20.65M | -55.61%20.84M | -55.61%20.84M | -41.59%32.57M | -19.62%28.5M |
| Receivables | ---- | ---- | ---- | ---- | ---- | --100K | ---- | ---- | --0 | -52.63%261K |
| -Accounts receivable | ---- | ---- | ---- | ---- | ---- | --100K | ---- | ---- | --0 | -52.63%261K |
| Prepaid assets | -69.21%653K | -46.65%995K | -46.65%995K | 87.80%1.77M | 137.27%2.8M | 169.16%2.12M | 218.80%1.87M | 218.80%1.87M | 152.14%943K | 103.10%1.18M |
| Total current assets | -61.79%8.74M | -85.95%3.19M | -85.95%3.19M | -76.59%7.85M | -53.42%13.95M | -40.84%22.87M | -52.56%22.71M | -52.56%22.71M | -41.33%33.51M | -18.17%29.94M |
| Non current assets | ||||||||||
| Net PPE | -89.97%72K | -36.83%482K | -36.83%482K | -46.45%521K | -28.02%560K | 275.92%718K | 190.11%763K | 190.11%763K | 190.45%973K | 90.69%778K |
| -Gross PPE | ---- | -5.50%2.34M | -5.50%2.34M | ---- | ---- | ---- | 44.85%2.47M | 44.85%2.47M | ---- | ---- |
| -Accumulated depreciation | ---- | -8.47%-1.86M | -8.47%-1.86M | ---- | ---- | ---- | -18.41%-1.71M | -18.41%-1.71M | ---- | ---- |
| Total non current assets | -89.97%72K | -36.83%482K | -36.83%482K | -46.45%521K | -28.02%560K | 275.92%718K | 190.11%763K | 190.11%763K | 190.45%973K | 60.08%778K |
| Total assets | -62.65%8.81M | -84.35%3.67M | -84.35%3.67M | -75.74%8.37M | -52.78%14.51M | -39.29%23.59M | -51.23%23.47M | -51.23%23.47M | -39.98%34.49M | -17.14%30.72M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -33.13%1.85M | -61.69%1.83M | -61.69%1.83M | -70.24%1.01M | -53.31%1.97M | -18.64%2.76M | -9.07%4.78M | -9.07%4.78M | -51.70%3.39M | -19.94%4.23M |
| -accounts payable | -33.13%1.85M | -61.69%1.83M | -61.69%1.83M | -70.24%1.01M | -53.31%1.97M | -18.64%2.76M | -9.07%4.78M | -9.07%4.78M | -51.70%3.39M | -19.94%4.23M |
| Current accrued expenses | -73.60%801K | -50.72%2.88M | -50.72%2.88M | -56.36%2.22M | -62.20%1.76M | -4.56%3.03M | 296.07%5.84M | 296.07%5.84M | 150.02%5.08M | 143.22%4.65M |
| Other current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --3.51M | ---- |
| Current liabilities | -56.82%2.65M | -55.66%4.71M | -55.66%4.71M | -70.99%3.98M | -58.28%4.25M | -23.74%6.13M | 25.46%10.62M | 25.46%10.62M | 12.81%13.7M | 15.20%10.18M |
| Non current liabilities | ||||||||||
| Derivative product liabilities | -95.21%704K | --4.46M | --4.46M | --4.05M | --5.7M | --14.7M | ---- | ---- | ---- | ---- |
| Preferred securities outside stock equity | ---- | ---- | ---- | --0 | --0 | --377K | --377K | --377K | ---- | ---- |
| Total non current liabilities | -95.33%704K | 1,082.23%4.46M | 1,082.23%4.46M | -57.60%4.05M | --5.7M | --15.08M | --377K | --377K | --9.55M | --0 |
| Total liabilities | -84.20%3.35M | -16.66%9.17M | -16.66%9.17M | -65.49%8.03M | -2.29%9.95M | 163.88%21.21M | 29.91%11M | 29.91%11M | 91.48%23.25M | 0.24%10.18M |
| Shareholders'equity | ||||||||||
| Share capital | -67.90%26K | -95.97%347K | -95.97%347K | -90.75%345K | 739.02%344K | 97.56%81K | 21,450.00%8.62M | 21,450.00%8.62M | 9,227.50%3.73M | 13.89%41K |
| -common stock | -67.90%26K | 133.33%14K | 133.33%14K | -71.43%12K | -73.17%11K | 97.56%81K | -85.00%6K | -85.00%6K | 5.00%42K | 13.89%41K |
| -Preferred stock | ---- | -96.13%333K | -96.13%333K | -90.97%333K | --333K | --0 | --8.61M | --8.61M | --3.69M | ---- |
| Retained earnings | -5.59%-442.15M | -6.59%-434.43M | -6.59%-434.43M | -7.65%-424.76M | -10.67%-418.45M | -15.12%-418.76M | -15.77%-407.55M | -15.77%-407.55M | -14.47%-394.57M | -13.42%-378.09M |
| Paid-in capital | 6.30%447.59M | 4.18%428.59M | 4.18%428.59M | 5.64%424.75M | 6.04%422.66M | 6.72%421.07M | 5.04%411.4M | 5.04%411.4M | 3.11%402.07M | 10.64%398.59M |
| Total stockholders'equity | 128.88%5.46M | -144.07%-5.5M | -144.07%-5.5M | -96.95%343K | -77.80%4.56M | -92.26%2.39M | -68.56%12.47M | -68.56%12.47M | -75.21%11.23M | -23.70%20.54M |
| Total equity | 128.88%5.46M | -144.07%-5.5M | -144.07%-5.5M | -96.95%343K | -77.80%4.56M | -92.26%2.39M | -68.56%12.47M | -68.56%12.47M | -75.21%11.23M | -23.70%20.54M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data